Avaxia Biologics
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
99 Hayden Ave, Lexington, Massachusetts,...Phone Number
(781) 861-0062Website
www.avaxiabiologics.comRevenue
$6.3 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Avaxia Biologics
Avaxia Biologics (www.avaxiabiologics.com) is a private, early stage company developing orally-delivered antibody therapeutics using a proprietary antibody platform. The company is pursuing products for oral mucositis, inflammatory bowel disease, and diabetes and obesity. Avaxia's lead product is a proprietary anti-TNF antibody to be administered to the oral cavity of patients suffering from mucositis. The antibody is designed to reduce the pain and ulceration associated with this serious side effect of cancer treatment. Avaxia is also developing a proprietary anti-TNF antibody to be administered orally to patients suffering from inflammatory bowel disease. Avaxia is also conducting discovery programs in the field of diabetes and obesity, targeting critical intestinal receptors associated with glucose metabolism.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Avaxia Biologics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Avaxia Biologics has new funding data
Avaxia Biologics, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Avaxia Biologics is spiking on competitors!
Check if Avaxia Biologics has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Avaxia Biologics recently announced quarterly report
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Avaxia Biologics
Click to see if Avaxia Biologics had a recent Job posting/layoffs
Product Launch: Get notified when Avaxia Biologics launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Avaxia Biologics
Compare insights from companies similar to Avaxia Biologics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Avaxia Biologics
$6.3M
11-50
Private
$24M
2005
N/A
Company Profile Activity
Activity Insights
Avaxia Biologics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Avaxia Biologics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Avaxia Biologics.
Avaxia Biologics financials insights
Gather financial insights about Avaxia Biologics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2012
Multiple Rounds
$17.1M
2013
Debt
$2.9M
2014
Debt
$3.1M
2015
Private Equity
$1M
Avaxia Biologics Tech Stack
A closer look at the technologies used by Avaxia Biologics
See more technologies
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Avaxia Biologics
Sign Up For FreeTo access detailed company insights
Avaxia Biologics (www.avaxiabiologics.com) is a private, early stage company developing orally-delivered antibody therapeutics using a proprietary antibody platform. The company is pursuing products for oral mucositis, inflammatory bowel disease, and diabetes and obesity. Avaxia's lead product is a proprietary anti-TNF antibody to be administered t... Read More
